Management of testicular seminoma

Seminars in Surgical Oncology

Volumn 17, Issue 4, 1999, Pages 240-249

  Milosevic, Michael F ^a,b   Gospodarowicz, Mary ^a   Warde, Padraig ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Adjuvant chemotherapy; Adjuvant radiotherapy; Alpha Fetoproteins; Bleomycin; Carbo platin; Chorionic gonadotropin; Cisplatin; Combined antineoplastic agents; Cyclophosphamide; Dactinomycin; Disease free survival; Dysgerminoma; Etoposide; Germ cell and embryonal neoplasms; HIV; Ifosfamide; Lactate dehydrogenase; Lymphatic metastasis; Neoplasm staging; Orchiectomy; Patient compliance; Phase III clinical trials; Prognosis; Radiation dose response relationship; Radiation induced neoplasms; Radiotherapy dosage; Recurrence; Retroperitoneal neoplasms; Risk factors; Second primary neoplasm; Seminoma; Testicular neoplasms; Vinblastine

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE;

CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; DECISION MAKING; HUMAN; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PRIORITY JOURNAL; REVIEW; SEMINOMA;

EID: 0032765233     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199912)17:4<240::AID-SSU4>3.0.CO;2-Q     Document Type: Review

References (68)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594-603.
3. Sobin LH, Wittekind C (eds): "TNM classification of malignant tumours." 5th ed. New York: Wiley-Liss; 1997.
4. Gauwitz MD, Zagars GK: Treatment of seminoma arising in cryptorchid testes. Int J Radiat Oncol Biol Phys 1992;24:153-159.
5. Li YX, Coucke PA, Qian TN, et al: Clinical characteristics, prognosis, and treatment of pelvic cryptorchid seminoma. Int J Radiat Oncol Biol Phys 1997;38:351-357.
6. Mason MD, Featherstone T, Olliff J, Horwich A: Inguinal and iliac lymph node involvement in germ cell tumours of the testis: implications for radiological investigation and for therapy. Clin Oncol (R Coll Radiol) 1991;3:147-150.
7. Skakkebaek NE, Berthelsen JG, Giwercman A, et al: Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987;10:19-27.
8. Giwercman A, von der Maase H, Skakkebaek NE: Epidemiological and clinical aspects of carcinoma in situ of the testis [Review]. Eur Urol 1993;23:104-114.
9. Dieckmann KP, Loy V: Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasia. J Clin Oncol 1996;14:3126-3132.
10. Wanderas EH, Fossa SD, Tretli S: Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer 1997;33:244-252.
11. Osterlind A, Berthelsen JG, Abildgaard N, et al: Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984. J Nat Cancer Inst 1991;83:1391-1395.
12. Grigor KM, Rorth M: Should the contralateral testis be biopsied? Round table discussion. Eur Urol 1993;23:129-135.
13. van der Schyff S, Heidenreich A: Tumor enucleation resection in testicular germ cell tumors: longterm follow-up [Abstract]. J Urol 1999;161:182.
14. Herr HW, Sheinfeld J: Is biopsy of the contralateral testis necessary in patients with germ cell tumors [Review]. J Urol 1997;158:1331-1334.
15. Weissbach L: Organ preserving surgery of malignant germ cell tumors. J Urol 1995;153:90-93.
16. Lyter DW, Bryant J, Thackeray R, et al: Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1995;13:2540-2546.
17. Leibovitch I, Baniel J, Rowland RG, et al: Malignant testicular neoplasms in immunosuppressed patients [Review]. J Urol 1996;155: 1938-942.
18. Timmerman JM, Northfelt DW, Small EJ: Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy. J Clin Oncol 1995;13: 1391-1397.
19. Fossa SD, Aass N, Kaalhus O: Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 1989;16: 383-388.
20. Dosmann MA, Zagars GK: Post-orchiectomy radiotherapy for stages I and II testicular seminoma. Int J Radiat Oncol Biol Phys 1993;26:381-390.
21. Warde P, Gospodarowicz MK, Panzarella T, et al: Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol 1995;13:2255-2262.
22. Yeoh E, Horowitz M, Russo A, et al: The effects of abdominal irradiation for seminoma of the testis on gastrointestinal function. J Gastroenterol Hepatol 1995;10:125-130.
23. Hamilton CR, Horwich A, Bliss JM, Peckham MJ: Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of thetestis. Radiother Oncol 1987;10:85-90.
24. Centola GM, Keller JW, Henzler M, Rubin P: Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl 1994;15:608-613.
25. Joos H, Sedlmayer F, Gomahr A, et al: Endocrine profiles after radiotherapy in stage I seminoma: impact of two different radiation treatment modalities. Radiother Oncol 1997;43:159-162.
26. Fraass BA, Kinsella TJ, Harrington FS, Glatstein E: Peripheral dose to the testes: the design and clinical use of a practical and effective gonadal shield. Int J Radiat Oncol Biol Phys 1985;11:609-615.
27. Travis LB, Curtis RE, Storm H, et al: Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Nat Cancer Inst 1997;89:1429-1439.
28. Travis L, Andersson M, Holowaty E, et al: Risk of leukemia following radiotherapy and chemotherapy for testicular cancer [Abstract]. J Clin Oncol 1999;18:308a.
29. Warde P, Gospodarowicz MK, Banerjee D, et al: Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 1997;157:1705-1710.
30. von der Maase H, Specht L, Jacobsen GK, et al: Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 1993;14:1931-1934.
31. Horwich A, Alsanjari N, A'Hern R, et al: Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 1992;65:775-778.
32. Warde P, Specht L, von der Masse H, et al: Prognostic factors for relapse in stage I seminoma managed by surveillance [Abstract]. J Urol 1999;161:158.
33. Oliver RT, Ong J, Harper P, et al: 10-year review of the Anglian Germ Cell Cancer Group adjuvant studies of carboplatin as an alternative to radiation or surveillance for stage I seminoma. In Jones WG, Appleyard I, Harnden P, et al. (eds): "Germ cell tumours IV." London: John Libbey and Co; 1998. p. 137-138.
34. Hao D, Seidel J, Brant R, et al: Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. J Urol 1998;160(3 Pt 1):768-771.
35. Sharda NN, Kinsella TJ, Ritter MA: Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 1996;14:2933-2939.
36. nd, Hornback NB: Testicular seminoma: analysis of treatment results and failures. Int J Radiat Oncol Biol Phys 1986;12:353-358.
37. Dosoretz DE, Shipley WU, Blitzer PH, et al: Megavoltage irradiation for pure testicular seminoma: results and patterns of failure. Cancer 1981;48:2184-2190.
38. Logue JP, Mobarek N, Read G: Para-aortic radiotherapy for stage I seminoma of the testis. In Jones WG, Appleyard I, Harnden P, et al. (eds): "Germ cell tumours IV." London: John Libbey and Co; 1998. p. 131-135.
39. Donohue JP, Zachary JM, Maynard BR: Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 1982;128: 315-320.
40. Sultanem K, Souhami L, Benk V, et al: Para-aortic irradiation only appears to be adequate treatment for patients with Stage I seminoma of the testis. Int J Radiat Oncol Biol Phys 1998;40: 455-459.
41. Kiricuta IC, Sauer J, Bohndorf W: Omission of the pelvic irradiation in stage I testicular seminoma: a study of postorchiectomy paraaortic radiotherapy. Int J Radiat Oncol Biol Phys 1996;35: 293-298.
42. Read G, Johnston RJ: Short duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study. Clin Oncol (R Coll Radiol) 1993;5:364-366.
43. Fossa SD, Horwich A, Russell JM, et al: Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. J Clin Oncol 1999;17:1146-1154.
44. Thomas GM: Alternative management options to radiation therapy for stage I and IIA testicular seminoma [editorial]. Int J Radiat Oncol Biol Phys 1994;28:547-548.
45. Donohue JP, Thornhill JA, Foster RS, et al: Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol 1993;149:237-243.
46. Schmidberger H, Bamberg M, Meisner C, et al: Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study [Review]. Int J Radiat Oncol Biol Phys 1997;39:321-326.
47. Oliver RT, Edmonds PM, Ong JY, et al: Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 1994;29:3-8.
48. Dieckmann KP, Krain J, Kuster J, Bruggeboes B: Adjuvant carboplatin treatment for seminoma clinical stage I. J Cancer Res Clin Oncol 1996;122:63-66.
49. Bauman GS, Venkatesan VM, Ago CT, et al: Postoperative radiotherapy for stage I/II seminoma: results for 212 patients. Int J Radiat Oncol Biol Phys 1998;42:313-317.
50. Hultenschmidt B, Budach V, Centers K, Sack HK: Results of radiotherapy for 230 patients with stage I-II seminomas. Strahlenther Onkol 1996;172:186-192.
51. Vallis KA, Howard GC, Duncan W, et al: Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients. Br J Radiol 1995;68:400-405.
52. Wards P, Gospodarowicz M, Panzarella T, et al: Management of stage II seminoma. J Clin Oncol 1998;16:290-294.
53. Warszawski N, Schmucking M: Relapses in early-stage testicular seminoma: radiation therapy versus retroperitoneal lymphadenectomy. Scand J Urol Nephrol 1997;31:355-359.
54. Hanks GE, Peters T, Owen J: Seminoma of the testis: long-term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 1992;24:913-919.
55. Lederman GS, Sheldon TA, Chaffey JT, et al: Cardiac disease after mediastinal irradiation for seminoma. Cancer 1987;60:772-776.
56. Loehrer PJ Jr, Birch R, Williams SD, et al: Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. J Clin Oncol 1987;5:1212-1220.
57. Fossa SD, Borge L, Aass N, et al: The treatment of advanced metastatic seminoma: experience in 55 cases. J Clin Oncol 1987;5:1071-1077.
58. Herr HW, Sheinfeld J, Pue HS, et al: Surgery for a post-chemotherapy residual mass in seminoma [Review]. J Urol 1997;157:860-862.
59. Ravi R, Ong J, Oliver RT, et al: The management of residual mass after chemotherapy in metastatic seminoma. BJU Int 1999; 83:649-653.
60. Culine S, Droz JP: Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everything [letter]. J Clin Oncol 1996;14:2884-2885.
61. Duchesne GM, Stenning SP, Aass N, et al: Radiotherapy after chemotherapy for metastatic seminoma - a diminishing role. MRC Testicular Tumour Working Party. Eur J Cancer 1997;33: 829-835.
62. Stanton GF, Bosl GJ, Whitmore WF Jr, et al: VAB-6 as initial treatment for patients with advanced seminoma. J Clin Oncol 1985;3:336-339.
63. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316:1435-1440.
64. Mencel PJ, Motzer RJ, Mazumdar M. et al: Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 1994;12:120-126.
65. Miller KD, Loehrer PJ, Gonin R, Einhorn LH: Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol 1997;15:1427-1431.
66. Toner GC, Panicek DM, Heelan RT, et al: Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 1990;8:1683-1694.
67. Mackey JR, Venner P: Seminoma with isolated central nervous system relapse, and salvage with craniospinal irradiation. Urology 1998;51:1043-1045.
68. Bokemeyer C, Nowak P, Haupt A, et al: Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 1997;15: 1449-1454.